载药阳离子传递体作为透皮给药载体的美洛昔康评价。
Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
机构信息
Faculty of Pharmacy, Silpakorn University, Sanamchan Palace campus, Nakhon Pathom, 73000, Thailand.
出版信息
AAPS PharmSciTech. 2013 Mar;14(1):133-40. doi: 10.1208/s12249-012-9904-2. Epub 2012 Dec 14.
Abstract
The aim of this study is to develop meloxicam (MX)-loaded cationic transfersomes as skin delivery carriers and to investigate the influence of formulation factors such as cholesterol and cationic surfactants on the physicochemical properties of transfersomes (i.e., particle size, size distribution, droplet surface charge and morphology), entrapment efficiency, stability of formulations and in vitro skin permeation of MX. The transfersomes displayed a spherical structure. Their size, charge, and entrapment efficiency depended on the composition of cholesterol and cationic surfactants in the formulation. Transfersomes provided greater MX skin permeation than conventional liposomes and MX suspensions. The penetration-enhancing mechanism of skin permeation by the vesicles prepared in this study may be due to the vesicle adsorption to and/or fusion with the stratum corneum. Our results suggest that cationic transfersomes may be promising dermal delivery carriers of MX.
摘要
本研究旨在制备负载美洛昔康（MX）的阳离子传递体作为皮肤给药载体，并考察胆固醇和阳离子表面活性剂等制剂因素对传递体（粒径、粒径分布、载药胶束表面电荷和形态）、包封率、制剂稳定性以及 MX 体外经皮渗透的影响。传递体呈现球形结构。其粒径、表面电荷和包封率取决于制剂中胆固醇和阳离子表面活性剂的组成。与传统脂质体和 MX 混悬剂相比，传递体增加了 MX 的皮肤渗透。本研究制备的囊泡的经皮渗透增强机制可能归因于囊泡对角质层的吸附和/或融合。研究结果表明，阳离子传递体可能是 MX 的有前途的经皮给药载体。
相似文献
1
Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
AAPS PharmSciTech. 2013 Mar;14(1):133-40. doi: 10.1208/s12249-012-9904-2. Epub 2012 Dec 14.
2
Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.
Int J Nanomedicine. 2014 Apr 29;9:2005-17. doi: 10.2147/IJN.S60674. eCollection 2014.
3
Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
Biol Pharm Bull. 2014;37(2):239-47. doi: 10.1248/bpb.b13-00576. Epub 2013 Nov 12.
4
Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.
J Drug Deliv. 2011;2011:418316. doi: 10.1155/2011/418316. Epub 2010 Nov 7.
5
Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Curr Drug Deliv. 2008 Jul;5(3):207-14. doi: 10.2174/156720108784911677.
6
Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
Pharm Dev Technol. 2013 Jul-Aug;18(4):779-86. doi: 10.3109/10837450.2011.598166. Epub 2011 Sep 14.
7
Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Life Sci. 2013 Nov 13;93(21):763-72. doi: 10.1016/j.lfs.2013.09.027. Epub 2013 Oct 7.
8
Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
Chem Phys Lipids. 2013 Oct-Nov;175-176:65-72. doi: 10.1016/j.chemphyslip.2013.07.010. Epub 2013 Aug 28.
9
Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Life Sci. 2013 Mar 14;92(6-7):383-92. doi: 10.1016/j.lfs.2013.01.005. Epub 2013 Jan 23.
10
Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam.
Int J Nanomedicine. 2020 Nov 24;15:9319-9335. doi: 10.2147/IJN.S274954. eCollection 2020.
引用本文的文献
1
Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.
Int J Pharm X. 2025 Apr 8;9:100333. doi: 10.1016/j.ijpx.2025.100333. eCollection 2025 Jun.
2
Layer-by-Layer Biopolymer-Coated Deformable Liposomes-In Situ Gel: A Hybrid Strategy for Enhanced Ocular Delivery of Itraconazole: In Vitro and In Vivo Appraisal.
Gels. 2024 Dec 31;11(1):19. doi: 10.3390/gels11010019.
3
Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs.
Pharmaceutics. 2024 May 16;16(5):675. doi: 10.3390/pharmaceutics16050675.
4
Optimizing fluconazole-embedded transfersomal gel for enhanced antifungal activity and compatibility studies.
Front Pharmacol. 2024 Mar 28;15:1353791. doi: 10.3389/fphar.2024.1353791. eCollection 2024.
5
Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies.
Int J Pharm X. 2024 Jan 16;7:100228. doi: 10.1016/j.ijpx.2023.100228. eCollection 2024 Jun.
6
Transfersome, an ultra-deformable lipid-based drug nanocarrier: an updated review with therapeutic applications.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):639-673. doi: 10.1007/s00210-023-02670-8. Epub 2023 Aug 19.
7
Bibliometric analysis and visualization of transdermal drug delivery research in the last decade: global research trends and hotspots.
Front Pharmacol. 2023 Jun 16;14:1173251. doi: 10.3389/fphar.2023.1173251. eCollection 2023.
8
Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma.
J Nanobiotechnology. 2023 Apr 28;21(1):139. doi: 10.1186/s12951-023-01877-4.
9
Formulation, characterization of glucosamine loaded transfersomes and in vivo evaluation using papain induced arthritis model.
Sci Rep. 2022 Nov 17;12(1):19813. doi: 10.1038/s41598-022-23103-1.
10
Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis.
R Soc Open Sci. 2022 Oct 5;9(10):220428. doi: 10.1098/rsos.220428. eCollection 2022 Oct.
本文引用的文献
1
Preparation and quality assessment of itraconazole transfersomes.
Int J Pharm. 2012 Oct 15;436(1-2):291-8. doi: 10.1016/j.ijpharm.2012.07.003. Epub 2012 Jul 11.
2
Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.
J Drug Deliv. 2011;2011:418316. doi: 10.1155/2011/418316. Epub 2010 Nov 7.
3
Liposome surface charge influence on skin penetration behaviour.
Int J Pharm. 2011 Jun 15;411(1-2):223-31. doi: 10.1016/j.ijpharm.2011.03.049. Epub 2011 Mar 31.
4
Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.
Int J Pharm. 2010 Jun 15;392(1-2):304-10. doi: 10.1016/j.ijpharm.2010.03.064. Epub 2010 Apr 8.
5
Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers.
Int J Pharm. 2010 Apr 15;389(1-2):18-23. doi: 10.1016/j.ijpharm.2010.01.007. Epub 2010 Jan 15.
6
A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Int J Pharm. 2010 Jan 29;385(1-2):12-9. doi: 10.1016/j.ijpharm.2009.10.013. Epub 2009 Oct 13.
7
New sucrose cocoate based vesicles: Preparation, characterization and skin permeation studies.
Colloids Surf B Biointerfaces. 2010 Jan 1;75(1):319-22. doi: 10.1016/j.colsurfb.2009.09.003. Epub 2009 Sep 8.
8
Liposomes and skin: from drug delivery to model membranes.
Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8.
9
Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
Int J Pharm. 2008 May 22;356(1-2):144-52. doi: 10.1016/j.ijpharm.2008.01.020. Epub 2008 Jan 19.
10
Effects of penetration enhancers on in vitro permeability of meloxicam gels.
Int J Pharm. 2007 Oct 1;343(1-2):26-33. doi: 10.1016/j.ijpharm.2007.04.011. Epub 2007 Apr 24.
Zotero 插件